Dr. Karan Seegobin, MD

Dr. Seegobin practices at Mayo Clinic Health System Mankato Hospital in Mankato, Minnesota.

Dr. Seegobin's NPI, 1225482888, was assigned on April 20, 2016. Dr. Seegobin holds Minnesota license 70057.

Dr. Seegobin's primary practice is Mayo Clinic Health System Mankato Hospital, at 1025 Marsh St, Mankato, MN 56001 in Blue Earth County. The practice phone is (507) 594-6449.

Dr. Seegobin's primary practice is Mayo Clinic Health System Mankato Hospital in Mankato, Minnesota. Dr. Seegobin is also affiliated with Mayo Clinic Health System in Mankato. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Seegobin to 4 more hospitals, 3 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seegobin practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Seegobin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Seegobin's licenses on file in 2 states: Minnesota and Florida.

CMS data shows 1,230 Medicare services from Dr. Seegobin across 7 procedure codes in 2024, for 351 Medicare patients. Medicare paid $61,814 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 351 Medicare patients who saw Dr. Seegobin in 2024. The largest group is 65 to 74, with 151 patients. 73% of them have high blood pressure, and 66% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seegobin's median patient age at 74, with 48% women.

In 2024, Dr. Seegobin wrote 1,587 Medicare Part D claims for 221 patients. 85% of them were for generic drugs. CMS names the drug for 1,334 of them, across 28 drugs with 11 or more claims each, at $965,802 in total drug cost. In 2023, CMS named 918 claims across 26 drugs.

Dr. Seegobin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seegobin as offering telehealth.

Dmand AI links 48 papers to Dr. Seegobin, published from 2015 to 2025. 2017 was the busiest year, with 15. The most frequent topics are Lymphoma, Large B-Cell, Diffuse. Dr. Seegobin has published most often in Clin Case Rep. Dr. Seegobin's most frequent co-authors are Satish Stephen Maharaj, MD, Simone M. Chang, MD and Cherisse Melissa Baldeo, MD.

CMS Open Payments shows 41 general payments to Dr. Seegobin from 19 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 68% of the total. Amgen Inc. paid the most, $480.